Artwork

Content provided by Clinical Care Options LLC and Clinical Care Options. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clinical Care Options LLC and Clinical Care Options or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Expert Discussions: Moving Beyond Lipid Lowering to Lower Risk in ASCVD and CKD

14:32
 
Share
 

Manage episode 436343080 series 3242427
Content provided by Clinical Care Options LLC and Clinical Care Options. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clinical Care Options LLC and Clinical Care Options or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the pathophysiology and novel therapeutic strategies to target residual inflammatory risk associated with ASCVD and CKD.  

 Episode outline:  

  • Moving beyond lipid lowering to address residual inflammatory risk
  • Novel anti-inflammatory targets for ASCVD

To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:  

  continue reading

28 episodes

Artwork
iconShare
 
Manage episode 436343080 series 3242427
Content provided by Clinical Care Options LLC and Clinical Care Options. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clinical Care Options LLC and Clinical Care Options or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the pathophysiology and novel therapeutic strategies to target residual inflammatory risk associated with ASCVD and CKD.  

 Episode outline:  

  • Moving beyond lipid lowering to address residual inflammatory risk
  • Novel anti-inflammatory targets for ASCVD

To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:  

  continue reading

28 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide